GORDON CARL L
SEC CIK 1282930 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ETRA | Electra Therapeutics, Inc. | Dir, 10% | 758.3K | $20.00M | — | 2 | 2026-09-21 | 2026-09-21 |
| BLSM | BlossomHill Therapeutics, Inc. | Dir | 2.09M | $10.00M | — | 2 | 2026-08-10 | 2026-08-10 |
| SCTX | Scribe Therapeutics, Inc. | Dir | 348.8K | $15.00M | — | 2 | 2026-07-27 | 2026-07-27 |
| KROS | Keros Therapeutics, Inc. | Dir | 759.2K | — | $11.00M | 3 | 2024-08-13 | 2025-11-21 |
| CMPX | Compass Therapeutics, Inc. | Dir, 10% | 0 | $20.66M | $5.68M | 5 | 2021-11-04 | 2025-04-09 |
| MBX | MBX Biosciences, Inc. | Dir, 10% | 747.9K | $14.02M | — | 3 | 2024-09-16 | 2025-02-14 |
| ACET | Adicet Bio, Inc. | Dir, 10% | 11.8K | $9.33M | — | 5 | 2021-12-10 | 2024-06-05 |
| HLSQ | Tessera Defense & Homeland Security Inc. | 10% | 13.77M | — | $9,251 | 2 | 2024-05-15 | 2024-05-15 |
| AVBP | ArriVent BioPharma, Inc. | Dir, 10% | 821.8K | $8.00M | — | 2 | 2024-01-30 | 2024-01-30 |
Transactions 26
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-09-23 17:35 | 2026-09-21 | ETRA | Electra Therapeutics, Inc. | GORDON CARL L | Dir, 10% | C - Cnv Deriv | — | +5.55M | 758.3K | New | — |
| DMI | 2026-09-23 17:35 | 2026-09-21 | ETRA | Electra Therapeutics, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $15.00 | +1.33M | 1.76M | +314% | +$20.00M |
| DMI | 2026-08-12 16:46 | 2026-08-10 | BLSM | BlossomHill Therapeutics, Inc. | GORDON CARL L | Dir | C - Cnv Deriv | — | +2.09M | 2.09M | New | — |
| DI | 2026-08-12 16:46 | 2026-08-10 | BLSM | BlossomHill Therapeutics, Inc. | GORDON CARL L | Dir | P - Purchase | $16.00 | +625.0K | 2.71M | +30% | +$10.00M |
| DI | 2026-07-29 18:50 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | GORDON CARL L | Dir | C - Cnv Deriv | — | +348.8K | 348.8K | New | — |
| DI | 2026-07-29 18:50 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | GORDON CARL L | Dir | P - Purchase | $15.00 | +1.00M | 1.35M | +287% | +$15.00M |
| MI | 2025-12-18 | 2025-11-21 | KROS | Keros Therapeutics, Inc. | GORDON CARL L | Dir | D - Sale to Iss | $17.75 | -214.5K | 759.2K | -22% | -$3.81M |
| D | 2025-06-06 | 2025-06-04 | KROS | Keros Therapeutics, Inc. | GORDON CARL L | Dir | A - Grant | $0.00 | +5,250 | 5,250 | New | $0 |
| I | 2025-04-11 | 2025-04-09 | CMPX | Compass Therapeutics, Inc. | GORDON CARL L | Dir, 10% | S - Sale | $1.59 | -3.57M | 0 | -100% | -$5.68M |
| MI | 2025-02-19 | 2025-02-14+ | MBX | MBX Biosciences, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $10.60 | +190.7K | 747.9K | +34% | +$2.02M |
| DMI | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $16.00 | +750.0K | 653.8K | New | +$12.00M |
| DMI | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | GORDON CARL L | Dir, 10% | C - Cnv Deriv | — | +3.06M | 403.8K | New | — |
| MI | 2024-08-15 | 2024-08-13 | KROS | Keros Therapeutics, Inc. | GORDON CARL L | Dir | S - Sale | $44.01 | -250.0K | 119.5K | -68% | -$11.00M |
| D | 2024-06-07 | 2024-06-05 | ACET | Adicet Bio, Inc. | GORDON CARL L | Dir, 10% | A - Grant | $0.00 | +5,900 | 11.8K | +100% | $0 |
| DI | 2024-05-20 | 2024-05-15 | HLSQ | Tessera Defense & Homeland Security Inc. | GORDON CARL L | 10% | S - Sale+OE | $0.38 | -24.3K | 13.77M | -0.2% | -$9,251 |
| DI | 2024-05-20 | 2024-05-15 | HLSQ | Tessera Defense & Homeland Security Inc. | GORDON CARL L | 10% | X - OptEx | $0.24 | +9.28M | 13.80M | +205% | +$2.23M |
| DMI | 2024-01-31 | 2024-01-30 | AVBP | ArriVent BioPharma, Inc. | GORDON CARL L | Dir, 10% | C - Cnv Deriv | — | +2.58M | 821.8K | New | — |
| DMI | 2024-01-31 | 2024-01-30 | AVBP | ArriVent BioPharma, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $18.00 | +444.4K | 1.51M | +42% | +$8.00M |
| MI | 2024-01-26 | 2024-01-25 | ACET | Adicet Bio, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $2.40 | +3.12M | 7.53M | +71% | +$7.50M |
| MI | 2023-06-29 | 2023-06-27 | ACET | Adicet Bio, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $2.09 | +875.0K | 1.03M | +572% | +$1.83M |
| D | 2023-06-02 | 2023-06-01 | ACET | Adicet Bio, Inc. | GORDON CARL L | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
| I | 2022-11-10 | 2022-11-08 | CMPX | Compass Therapeutics, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $3.21 | +402.0K | 15.22M | +3% | +$1.29M |
| MI | 2022-05-13 | 2022-05-11+ | CMPX | Compass Therapeutics, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $2.18 | +192.5K | 14.69M | +1% | +$420.5K |
| MI | 2022-05-10 | 2022-05-06+ | CMPX | Compass Therapeutics, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $1.57 | +125.4K | 14.51M | +0.9% | +$197.3K |
| I | 2021-12-14 | 2021-12-10 | ACET | Adicet Bio, Inc. | GORDON CARL L | Dir, 10% | A - Grant | $14.00 | +214.3K | 242.3K | +765% | +$3.00M |
| MI | 2021-11-08 | 2021-11-04 | CMPX | Compass Therapeutics, Inc. | GORDON CARL L | Dir, 10% | P - Purchase | $3.50 | +5.36M | 3.57M | New | +$18.75M |